Cyclerion Therapeutics, Inc. Quarterly Operating Margin in % from Q4 2020 to Q3 2023

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Cyclerion Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2020 to Q3 2023.
  • Cyclerion Therapeutics, Inc. Operating Margin for the quarter ending September 30, 2023 was -172 %, a 94.1% increase year-over-year.
  • Cyclerion Therapeutics, Inc. annual Operating Margin for 2022 was -6.24K %, a 346% decline from 2021.
  • Cyclerion Therapeutics, Inc. annual Operating Margin for 2021 was -1.4K %, a 60.4% increase from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2023 -172 +2.75K +94.1% Jul 1, 2023 Sep 30, 2023
Q2 2023 -380 +2.36K +86.1% Apr 1, 2023 Jun 30, 2023
Q1 2023 2.13K +3.33K Jan 1, 2023 Mar 31, 2023
Q4 2022 -6.24K -4.84K -346% Oct 1, 2022 Dec 31, 2022
Q3 2022 -2.92K -1.23K -72.4% Jul 1, 2022 Sep 30, 2022
Q2 2022 -2.74K -780 -39.7% Apr 1, 2022 Jun 30, 2022
Q1 2022 -1.19K +4.32K +78.3% Jan 1, 2022 Mar 31, 2022
Q4 2021 -1.4K +2.14K +60.4% Oct 1, 2021 Dec 31, 2021
Q3 2021 -1.7K Jul 1, 2021 Sep 30, 2021
Q2 2021 -1.96K Apr 1, 2021 Jun 30, 2021
Q1 2021 -5.51K Jan 1, 2021 Mar 31, 2021
Q4 2020 -3.54K Oct 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.